2016-03-28 |
|
|
and Dismissal of Counterclaims of U.S. Patent Nos. 7,741,358 and 8,022,228 (Hikma and West-Ward), filed… 14 September 2020
1:14-cv-01119
830 Patent
None
District Court, D. Delaware
|
External link to document |
2014-09-03 |
1 |
|
paragraphs 1-20.
22, United States Patent No. 7,741,358 (“the ’358 patent”), titled “Crystal Forrn of
Asenapine…United States Patent No. 7,741,358 constitute
infringement of one or more claims of said patent under 35 U.S.C…:
a) declare that United States Patent Nos. 5,763,476 and 7,741,358 are valid;
b) declare that, under…Sigmapharm infringed
United States Patent Nos. 5,763,476 and 7,741,358 by submitting ANDA No. 206107 to …expiration date of United States Patent
Nos. 5,763,476 and 7,741,358, including any exclusivities or extensions |
External link to document |
2016-01-28 |
133 |
|
language of U.S. Patent Nos. 5,763,476,
(the '476 patent), 7,741,358 (the '358 patent), and 8,022,228…1 of the '228 patent which shares a specification with the '358
patent. All references in …8,022,228 (the '228 patent) shall be
construed consistent with the tenets of claim construction … The '476 Patent
1. "Tension, excitation, anxiety…the time, evidenced by applicants' separate patent application (No.
11/247,342) for the treatment |
External link to document |
2016-03-24 |
174 |
|
and Dismissal of Counterclaims of U.S. Patent Nos. 7,741,358 and 8,022,228 (Hikma and West-Ward) by Forest… 14 September 2020
1:14-cv-01119
830 Patent
None
District Court, D. Delaware
|
External link to document |
2016-04-11 |
179 |
|
crystalline form, as required by claim
1 of U.S. Patent No. 7,741,358. An issue that not atypically arises in … 14 September 2020
1:14-cv-01119
830 Patent
None
District Court, D. Delaware
|
External link to document |